Laminin-5 Mutational Analysis in an Italian Cohort of Patients with Junctional Epidermolysis Bullosa  by Posteraro, Patrizia et al.
See related Commentary on page xii
Laminin-5 Mutational Analysis in an Italian Cohort of Patients
with Junctional Epidermolysis Bullosa
Patrizia Posteraro, Naomi De Luca,w Guerrino Meneguzzi,z May El Hachem,y Corrado Angelo,z
Tommaso Gobello,# Gianluca Tadini, Giovanna Zambruno,w and Daniele Castigliaw
Department of Clinical and Molecular Pathology, IDI-IRCCS, Rome, Italy; wLaboratory of Molecular and Cell Biology, IDI-IRCCS, Rome, Italy; zINSERM U634,
Faculte´ de Me´decine, Nice, France; yDermatology Division, Ospedale Bambino Gesu`-IRCCS, Rome, Italy; zVII Dermatology Division, IDI-IRCCS, Rome, Italy;
#VIII Dermatology Division, IDI-IRCCS, Rome, Italy; Institute of Dermatological Sciences, Policlinico of Milano, IRCCS, Italy
Junctional epidermolysis bullosa (JEB) is a rare genodermatosis characterized by dermal–epidermal separation
that is caused by mutations in the genes encoding hemidesmosomal components and laminin-5, the major ep-
ithelial adhesion ligand. Here, we report on the mutational analysis of LAMA3, LAMB3, and LAMC2 genes encoding
laminin-5 chains in 19 Italian patients, 11 affected with the severe Herlitz (H JEB) and eight with the mild non-Herlitz
variant of JEB (non-H JEB). Eighteen mutations, seven of which were novel, were identiﬁed and their consequences
analyzed at the mRNA and protein level. Premature termination codon mutations in both alleles of LAMB3 or
LAMC2 genes were found in nine of the 11 H JEB patients, with a prevalence of mutations in LAMC2. In one case, a
homozygous frameshift mutation in LAMB3 was associated to illegitimate splicing leading to non-H JEB. One H
JEB patient showed a large intragenic duplication within LAMC2, a genetic defect so far uncovered in laminin-5
genes. Splicing or missense mutations, were prevalent in non-H JEB patients. Collectively, ﬁve mutations appeared
to be frequent in laminin-5 JEB patients: R635X, 29insC, E210K, W143X in LAMB3 and R95X in LAMC2. These
recurrent mutations account for approximately 44% of laminin-5 JEB alleles in Italian patients.
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Junctional epidermolysis bullosa (JEB) is a recessively in-
herited skin disorder characterized by fragility of skin and
mucous membranes and by tissue separation within the
lamina lucida of the cutaneous basement membrane zone
(BMZ) (Fine et al, 2000). Ultrastructural findings in JEB
comprise abnormalities in the hemidesmosome (HD)-an-
choring filament complexes, adhesion devices of basal
keratinocytes that link the keratin cytoskeleton to the
lamina densa of the BMZ (Burgeson and Christiano, 1997;
Borradori and Sonnenberg, 1999).
The majority of JEB cases is caused by defects in la-
minin-5, the major adhesion ligand of basal epithelial cells
expressed in the BMZ of the skin and mucous epithelia
(Marinkovich et al, 1992; Colognato and Yurchenco, 2000).
Specifically, global analysis of laminin-5 mutation database
indicates that null mutations in the LAMA3, LAMB3, or
LAMC2 genes encoding for the laminin-5 a3, b3, and g2
chains lead to the absence of laminin-5 that correlates with
rudimentary/absent HD and severe defects in epithelial cell
adhesion. These features are the hallmarks of the lethal
Herlitz JEB variant (H JEB, OMIM 226700) (Pulkkinen et al,
1997b; Bauer et al, 2002). Other mutations, in most cases
missense or in frame deletions in one or both alleles of the
laminin-5 genes, cause a reduced expression of aberrant
laminin-5 molecules that retain a residual biological activity,
which results in the limited tendency to blistering distinctive
of the mild non-Herlitz JEB (non-H JEB, OMIM 226650)
(Posteraro et al, 1998; Castiglia et al, 2001, Nakano et al,
2002a; Scaturro et al, 2003). Homozygous premature ter-
mination codon (PTC) mutations in laminin-5 genes, how-
ever, have been associated to either lethal and non-lethal
JEB phenotypes (Pulkkinen and Uitto, 1998; McGrath et al,
1999; Gache et al, 2001; Nakano et al, 2002a). Other studies
have demonstrated the existence of a unique spectrum of
recurrent mutations in defined populations (Shimizu et al,
1996; Nakano et al, 2002b), suggesting the usefulness of a
diagnostic approach specifically designed for JEB patients
of particular geographical areas. Finally, it is known that
non-H JEB can also result from genetic defects in the
COL17A1 gene encoding the hemidesmosomal component
collagen XVII (Fine et al, 2000; Bauer and Lanschuetzer,
2003).
In this study, we have examined a cohort of 19 Italian
JEB patients presenting laminin-5 defective expression, 11
of them affected with H JEB and eight with non-H JEB. A
total of 18 pathogenic mutations were characterized, in-
cluding six novel point mutations and a gross genomic re-
arrangement within LAMC2, a genetic defect described for
the first time in laminin-5 genes. Five mutations are frequent
Abbreviations: BMZ, basement membrane zone; HD, hemidesmo-
some; H JEB, Herlitz junctional epidermolysis bullosa; non-H JEB,
non-Herlitz junctional epidermolysis bullosa; PTC, premature ter-
mination codon
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in the Italian population: four affect LAMB3 and one LAMC2.
Mutation consequences at mRNA and protein level are also
elucidated.
Results
Clinical ﬁndings All the 19 Italian patients affected with
JEB (Table I) displayed skin blistering since birth. The clin-
ical diagnosis was ascertained by immunofluorescence an-
tigen mapping that showed reduced or absent staining of
the cutaneous BMZ with GB3 antibody that recognizes
heterotrimeric laminin-5. In addition, the level of the blister
plane was assessed by labeling for type IV and VII collagens
that localized to the blister floor, and staining for a6b4 in-
tegrin and collagen XVII that was detected in the blister roof.
Transmission electron microscopy examination, performed
in most of the patients, further confirmed the diagnosis of
JEB showing cleavage within the lamina lucida. In addition,
HD alterations were detected in all examined patients and
comprised a complete or partial absence of sub-basal
dense plates and a reduction in size of a variable proportion
of cytoplasmic plaques as well as of the number of plaque-
associated tonofilaments (Table I). Eleven probands were
classified as H JEB on the basis of: (i) a progressive wors-
ening of skin and mucosal involvement in the neonatal pe-
riod with demise within infancy in all patients except one
who survived until the age of 10 y; and (ii) absent or barely
detectable laminin-5 staining (Table I). In addition, H JEB
patients displayed marked alterations of HD that regularly
lacked sub-basal dense plates and frequently showed high-
ly reduced or even absent cytoplasmic inner plaques. The
remaining eight patients, aged between 10 and 59 y, pre-
sented normal growth and less severe skin blistering with
occasional and mild mucosal involvement: they were thus
classified as non-H JEB. Phenotypic differences among the
non-H JEB patients mainly concerned the extent of skin
lesions that ranged from generalized to localized blistering
limited to trauma-exposed sites. All non-H JEB patients
showed nail dystrophy and dental abnormalities with pitting
enamel hypoplasia and extensive caries. Hair involvement
was observed in only two patients (no. 13 and 17). The skin
of all non-H JEB patients presented a detectable immuno-
reactivity for laminin-5, the labeling intensity being reduced
to different extent from case to case (Table I).
Laminin-5 mutation survey in the Italian population He-
teroduplex analysis of genomic fragments, corresponding
to the coding regions and the exon–intron boundaries of the
LAMA3, LAMB3, LAMC2 genes, and in some cases RT-PCR
and sequencing of the entire cDNA of these three genes
allowed us to identify the pathogenic mutations in all
patients. Through these screening methods, an overall
mutation detection sensitivity of 95% was obtained: ho-
mozygous pathogenic sequence variations were detected
in ten individuals and compound heterozygous mutations in
nine others (Table I). Six H JEB patients had mutations in
LAMC2 and five in LAMB3; among non-H JEB patients, four
carried mutations in LAMB3, three in LAMA3, and one in
LAMC2. We identified a constellation of 18 mutations, in-
cluding six insertion/deletion, six nonsense mutations, four
splice site muations, one missense mutation, and a gen-
omic DNA rearrangement leading to partial duplication of
LAMC2 (Table II). DNA-based prenatal testing was also
performed in four families at risk for recurrence of H JEB
(Table I).
Novel mutations Seven novel mutations were identified in
the cohort of Italian JEB patients. Three of these were non-
sense mutations, two affected splice sites, one was a 2 bp
deletion, and one was a partial gene duplication (Tables I
and II).
Four of seven novel mutations were in LAMC2. Mutation
1899delGC, localized in exon 12, leads to PTC formation
within the C-terminus of domain III of the g2 polypeptide
(Kallunki et al, 1992). This mutation was identified at a ho-
mozygous state in the H-JEB patient 10. The nonsense
mutation Q908X (2839C ! T), localized in domain I of the
g2 chain, was identified in homozygosity in patient 11. The
nonsense mutation R223X (784C ! T), found in compound
heterozygosity with a complex rearrangement of LAMC2 (H
JEB patient 9), was detected by RT-PCR amplification of the
patient’s mRNA and direct sequencing of a LAMC2 cDNA
fragment spanning exons 5–8. Mutation inheritance was
confirmed on genomic DNA of the proband (Fig 1a) and her
mother (not shown). In the same patient, RT-PCR analysis of
the mRNA region encompassing exons 5–8 also showed
the presence of a slow migrating cDNA fragment, in addi-
tion to the normal-sized band (not shown). Direct se-
quencing of this fragment revealed a complex configuration
of exons: a cDNA region, corresponding to exons 11–18
of LAMC2 was inserted in frame between exons 6 and 7
(Fig 1b). Sequence analysis of the mutant cDNA revealed
that patient’s keratinocytes express an abnormal LAMC2
mRNA transcript of 1286 bp longer than wild-type counter-
part, because of duplication of the fragment spanning ex-
ons 11–18. In keeping with these findings, northern blot
analysis of the patient’s RNA showed the presence of a
single faint band corresponding in size to the aberrant
longer mRNA (5.3 kb) carrying the exon duplication (Fig 1c).
The LAMC2 gene, mapped to chromosome 1q25, spans
55 kb and consists of 23 exons. Its EcoRI restriction map
and assignment of exons to the restriction fragments have
been determined (Airenne et al, 1996). To establish whether
the exon rearrangement observed at the mRNA level re-
flected a gross molecular abnormality in the structure of
LAMC2, we performed a Southern blot analysis of the pro-
band’s genomic DNA digested with EcoRI. Independent
hybridizations with probes corresponding to exons 6 and 18
that flank the putative duplicated region of LAMC2 detected
the expected DNA fragments of 1.3 kb (exon 6) and 2.0 kb
(exon 18) both in the patient and normal control, whereas
additional bands of 3.1 kb (exon 6 probe) and 1.4 kb (exon
18 probe) were detected in the patient’s DNA (Fig 1d). These
additional bands confirmed the presence of an abnormal
arrangement of genomic elements within the paternal LAM-
C2 allele, and localized the junctions of the inserted DNA
segment at the sides of exons 6 and 18. PCR assays were
then performed to identify breakpoints flanking the dupli-
cated DNA segment. Using the primer pairs In5F–In11R and
In17F–In7R (see Materials and Methods), two PCR products
of 1.2 and 1.5 kb, respectively, were obtained in the patient
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and her father, but not in the normal control and patient’s
mother (Fig 1e, f). Sequencing of these abnormal PCR am-
plification products localized the breakpoints of the up-
stream junction within introns 6 and 10, and those of the
downstream junction within introns 18 and 6, both in regions
showing little homology (less than 50%). In the upstream
junction, breakpoints were localized at the level of a short 7
bp sequence motif shared by introns 6 and 10 (Fig 1g, up-
per). The downstream junction contained the insertion of
two cytosine residues at the breakpoints (Fig 1g, lower).
Thus, the duplication spans approximately 8.0 kb, from in-
trons 10 to 18, and was designated Ex11_Ex18dup (Fig 1h).
Two novel mutations were identified within LAMA3: the
splice site mutation 361A ! G (S121G) was detected at
the homozygous state in patient 18 and in compound
heterozygosity with the other novel splicing mutation
3317þ1G ! A in patient 19 and her sister (Fig 2a). These
patients belong to related families and present a mild non-H
JEB phenotype with skin lesions predominantly (patient 19)
or exclusively (patient 18) localized to trauma-exposed sites.
Mutation 3317þ 1G ! A abolishes the conserved donor
splice site of intron 25 (Fig 2c, right panels). Total RNA from
cultured keratinocytes of patient 19 was therefore analyzed
by RT-PCR using primers spanning exon 25. Examination of
the resulting PCR products on 2% agarose gel revealed an
aberrant band of 455 bp, in addition to the expected band of
516 bp. The sequence of this aberrant cDNA product iden-
tified an out-of-frame transcript originating from the usage
of a cryptic splice site localized within exon 25, 61 nts
upstream from the donor splice site of intron 25 (Fig 2d,
right panel). The other mutation, 361A ! G, results in the
Ser121 ! Gly substitution (Fig 2c, left panels). Since muta-
tion 361A ! G occurs at position 2 of the donor splice site
of intron 3, an aberrant splicing could also be expected. RT-
PCR analysis confirmed the presence of an aberrant band of
444 bp, in addition to the expected 554 bp band (Fig 2d, left
panel). Direct sequencing of the aberrant 444 bp fragment
identified an abnormal mRNA transcript bearing the out-of-
frame deletion of exon 3 (110 bp). Direct sequencing of the
554 bp fragment revealed the second mutant full-length
mRNA carrying missense mutation S121G, which is com-
patible with the synthesis of a normal-sized a3 polypeptide,
as confirmed by immunoprecipitation analysis of patient’s
cultured keratinocytes (not shown). In keeping with these
findings, BMZ labeling for laminin-5 was clearly detectable in
patient 19 (Fig 2b) and patient 18.
Table II. Laminin-5 mutation types in Italian JEB patients
Type of mutation Gene Position Reference
Insertion/deletion
29insC LAMB3 Exon 3 Pulkkinen et al (1995b)
904delT LAMB3 Exon 9 Posteraro et al (1998)
1587delAGa LAMB3 Exon 13 Gache et al (2001)
3511insA LAMC2 Exon 23 Castiglia et al (2001)
1899delGC LAMC2 Exon 12 This study
1644delG LAMA3 Exon 14 Scaturro et al (2003)
Nonsense mutations
R95X (400C ! T) LAMC2 Exon 3 Aberdam et al (1994)
R223X (784C ! T) LAMC2 Exon 6 This study
Y355X (1182C ! G) LAMC2 Exon 8 Baudoin et al (1994)
Q908X (2839C ! T) LAMC2 Exon 18 This study
W143X (429G ! A) LAMB3 Exon 6 This study
R635X (1903C ! T) LAMB3 Exon 14 Pulkkinen et al (1994)
Splicing mutations
361A ! G (S121G) LAMA3 Exon 3 This study
3317þ1G ! A LAMA3 Intron 25 This study
628G ! A (E210K) LAMB3 Exon 7 McGrath et al (1995)
522-1G ! A LAMC2 Intron 3 Castiglia et al (2001)
Missense mutation
G1506E (4517G ! A) LAMA3 Exon 34 Scaturro et al (2003)
Complex rearrangement
Ex11_Ex18dup LAMC2 Intron 6 This study
aPTC mutation associated to illegitimate splicing.
Nucleotide change is according to the translation initiation codon of
LAMB3 cDNA (GenBank L25541) and LAMA3 cDNA (GenBank L34155)
or according to the most upstream nucleotide of LAMC2 cDNA (GenBank
Z15008). JEB, junctional epidermolysis bullosa; PTC, premature termi-
nation codon.
Figure 1
Patient 9: molecular characterization. (a) Nucleotide sequencing of exon 6 in LAMC2 reveals a heterozygous C to T transition changing arginine
223 to a nonsense codon (R223X). (b) Schematic showing the unusual order of exons identified in the patient’s LAMC2 cDNA amplified with primers
covering exons 5–8 (arrows). The nucleotide sequence of the aberrant splicing junctions between exons 6 and 11 and exons 18 and 7 is also shown.
(c) Highly reduced levels of an aberrant g2 chain mRNA of increased size (5.3 kb) are observed in patient’s keratinocytes (P) in comparison with
normal control cells (C). Note the absence of normal-sized mRNA in the patient. (d) Southern blot analysis of EcoRI restricted genomic DNA from the
proband and a healthy control was performed with 32P-labeled LAMC2 probes corresponding to exons 6 and 18. A single EcoRI fragment of 1.3 kb
(exon 6 probe) and 2.0 kb (exon 18 probe) is observed in the normal control (C). An additional EcoRI fragment of 3.1 kb (exon 6 probe) and 1.4 kb
(exon 18 probe) is present in the proband (P). Mw: lDNA EcoRI/HindIII fragments. (e) Primers annealing within intron 5 (In5F) and intron 11 (In11R)
were used for long-range PCR analysis on genomic DNA from patient (P), father (F), mother (M), and an unrelated healthy control (C). In the control
and the mother, PCR amplification results in the presence of a  7 kb band, whereas in the patient and her father, an additional aberrant PCR
fragment of  1.2 kb is observed. A further expected aberrant fragment of 415 kb was not amplified under these PCR conditions. Mw: lDNA
EcoRI/HindIII fragments. (f) Long-range PCR assay using primers that hybridize to intron 17 (In17F) and intron 7 (In7R) reveals a specific band of
 1.5 kb in the patient (P) and her father (F), but not in the mother (M) and control (C). Mw: 100 bp DNA ladder. (g) Nucleotide sequences of the
junction fragments showing the position of the breakpoints. Alignment of the wild-type sequences of introns 6 and 10 with the 50 junction sequence
(upper panel). The boxed nucleotides indicate the 7 bp motif shared by introns 6 and 10. In the lower panel, the sequence of the 30 junction between
introns 18 and 6 is shown. The two novel filler cytosine introduced at the breakpoints are boxed. (h) Schematic representation of the genomic
structure of the mutant LAMC2 alleles of the patient. Exons are shown by vertical bars. For clarity, only the EcoRI sites (E) involved in rearrangements
are indicated. In the upper part, the mutated R223X allele with a normal exon–intron structure is reported. In the lower part, the mutant allele
harboring duplication of the gene segment encompassing exons 11–18 (in red) is shown. In this representation, the novel positions of EcoRI sites are
indicated, as deduced by Southern blot (d) and nucleotide sequencing results. Scale bar: 10 kb.
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The last novel mutation, designated W143X (429G ! A),
was found in LAMB3. This nonsense mutation, localized
in the N-terminal domain VI of the b3 chain, was identified in
homozygosity in two H JEB cases (patients 2 and 3). In
addition to the novel mutation W143X, the previously re-
ported mutation 1587delAG in exon 13 of LAMB3 (Gache
et al, 2001) was identified for the first time at the ho-
mozygous state, thus allowing to completely define mRNA,
protein, and phenotypic mutation consequences (Fig 3c).
Deletion 1587delAG leads to a frameshift and predicts the
formation of a downstream PTC in exon 14, nevertheless it
was found in a non-H JEB case. This patient (no. 15) was
born from healthy consanguineous parents and presented a
mild skin involvement, no mucosal lesions and dental and
nail dystrophy. RT-PCR and northern blot analyses per-
formed on RNA from patient’s keratinocytes revealed a sin-
gle, relatively abundant mRNA species of shortened length,
which was also detected at extremely low amount in normal
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control keratinocytes. Direct sequencing of this aberrant
band identified an in-frame mRNA transcript carrying both
mutation 1587delAG in exon 13 and the entire deletion of
exon 14 (379 bp) (Fig 3d). The presence of this stable tran-
script leads to the synthesis and secretion of a shortened b3
chain (130 kDa), as detected by immunoprecipitation anal-
ysis (Fig 3b), and is in keeping with the reduced amount of
immunoreactive laminin-5 observed along the dermo-epi-
dermal junction of the patient’s skin (Fig 3a).
Recurrent mutations This study has shown the presence
of several recurrent mutations that were present at least in
two unrelated Italian JEB families: four in LAMB3 (R635X,
29insC, E210K, and W143X) and one in LAMC2 (R95X) (Ta-
ble II). The hot spot mutation R635X (10.5% of the mutated
alleles), as well as mutations E210K (5.3%), and 29insC
(7.9%) have also been observed in patients from other
countries (McGrath et al, 1995; Pulkkinen et al, 1995b,
1997b) and were not restricted to a particular Italian geo-
graphic area. On the other hand, the R95X (10.5%) and the
novel W143X (10.5%) mutations have been detected only
in Italian patients from southern Italian regions, Sicily and
Campania, respectively. Mutation W143X was identified in
H JEB patients 2 and 3, both first sons of healthy, non-
consanguineous parents. The mutant alleles in these two
families were assessed for the presence or absence of
six common, non-pathogenetic intragenic polymorphisms
(Ashton et al, 1997) (not shown). All the mutant alleles had
identical haplotypes for the six polymorphisms examined,
thus supporting propagation of a common Italian ancestral
LAMB3 allele for this novel mutation.
All the recurrent mutations can be detected by PCR and
restriction endonuclease digestion or by direct sequencing
(Table III).
Discussion
This report describes the results of the molecular analysis in
19 Italian families with JEB; this sample includes patients
referred to our Departments for clinical and molecular di-
agnosis between 1996 and 2003. Eleven cases investigated
were affected with H JEB and eight patients suffered from
non-H JEB. According to the Italian Register of EB (man-
uscript in preparation), 12 families are affected by H JEB
and 46 by non-H JEB, the latter comprising cases due to
laminin-5 or collagen XVII gene mutations (Fine et al, 2000).
Thus, the molecular analysis reported in this study covers
about one-third of the Italian H and non-H JEB families and
the large majority of H JEB patients included in the Italian
EB Register. As to non-H JEB cases showing defective
collagen XVII expression, the recurrent Italian mutation
R795X (Ruzzi et al, 2001) has been identified in four Italian
families and mutational analysis of the COL17A1 gene in
five additional families has been performed or is underway
(P. Posteraro, unpublished data), indicating that also in the
Italian population a significant proportion of non-H JEB
cases is caused by COL17A1 mutations (Bauer and La-
nschuetzer, 2003).
The diagnosis in the patients investigated was made on
the basis of clinical signs, abnormal expression of laminin-5
by antigen mapping, and ultrastructural evidence of der-
mal–epidermal cleavage within the lamina lucida. Our data
Figure 2
Patient 19: clinical and molecular character-
ization. (a) Skin erosions at trauma-exposed
sites (elbow, hands) and nail dystrophy. (b)
Immunofluorescence staining of skin biopsies
from the proband and a control individual using
an anti-laminin-5 monoclonal antibody (GB3)
gives a linear labeling at dermal–epidermal junc-
tion of reduced intensity in the proband com-
pared with normal control skin. Scale bar: 40 mm.
(c) Identification of the maternal 361A ! G (up-
per left panel) and paternal 3317þ1G ! A (up-
per right panel) mutations in exon 3 and intron 25
of the LAMA3 gene. The chromatograms in the
left panels show the nucleotide sequence of the
antisense strand. (d) Effects of mutations
361A ! G and 3317þ 1G ! A at mRNA level.
RT-PCR amplification performed with primers
spanning exon 3 gives a 444 bp band in the pa-
tient’s sample, corresponding to an abnormal
transcript bearing the out-of-frame deletion of
exon 3. In addition, sequencing of the 554 bp
revealed the presence of a normal spliced tran-
script carrying an amino acid substitution at co-
don 121 (left panel). Examination of the cDNA
products amplified with primers spanning exon
25 reveals an aberrant band of 455 bp in the
patient’s sample. This fragment corresponds to
an out-of-frame transcript carrying the deletion
of 61 bp, as a consequence of the activation of a
criptic donor splice site within exon 25 (right
panel). In both panels the genomic structure of
the LAMA3 exons and the aberrantly spliced
transcripts are schematically represented. Mw:
100 bp DNA ladder.
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demonstrate a preponderance of mutations in the LAMB3
gene (47% of mutated alleles), followed by a 37% and 16%
of alleles carrying mutations in LAMC2 and LAMA3, re-
spectively. This observation confirms the prevalence in JEB
of LAMB3 mutations, which have been reported to account
for approximately 80% of laminin-5 genetic defects world-
wide (Nakano et al, 2002a). The high proportion of muta-
tions in LAMB3 is mainly due to the recurrence of the
hotspot mutation R635X, which represents 45% of all mu-
tated LAMB3 alleles in Caucasian H JEB patients and is
particularly frequent in France and in northern European
countries (Pulkkinen et al, 1997b; Nakano et al, 2000). Spe-
cifically in the Scandinavian population, mutation R635X
appears to represent an ancient sequence variation that has
spread due to limited founder pool, genetic drift, and
healthy carrier migration (Gedde-Dahl and Anton-Lamp-
recht, 1996).
In addition, other mutations that are frequently found in
certain populations also affect LAMB3 (Takizawa et al, 1998;
Nakano et al, 2000). LAMB3 mutation R635X, however, was
detected in only 14% of Italian H JEB mutant alleles,
whereas six of 11 H JEB Italian patients carried mutations in
the LAMC2 gene. Thus, discrepancy in mutation frequency
among laminin-5 genes may reflect patient ethnic origin.
Indeed, the R635X mutation in LAMB3 was not found in
the Middle East and Japanese populations (Takizawa et al,
1998; Nakano et al, 2002b).
The data reported conform to the general experience
of the genotype–phenotype correlation in this gen-
odermatosis. In particular, in H JEB PTC mutations were
prevalent (20 of 22 alleles) and present on both alleles in
nine of 11 patients. One H JEB patient was a compound
heterozygote for a PTC mutation and a large duplication in
LAMC2 that has been shown to span  8000 nucleotides,
from introns 10 to 18. At the mRNA level, the duplication
mutation resulted in a large, barely detectable transcript.
This transcript is predicted to synthesize a g2 polypeptide
that is elongated by 429 amino acids, corresponding to part
of domain I, the entire domain II, and part of domain III,
inserted within the globular domain IV. This large duplication
mutation is therefore expected to severely compromise the
structural organization of the g2 short arm, leading to pro-
tein degradation. Thus, combined mutation effects on
mRNA and protein level result in the severe phenotype ob-
served in this patient who died at the age of 3 mo. Partial
gene duplications have been rarely described in patients
with different inherited diseases, such as Duchenne and
Becker muscular dystrophy, familial hypercholesterolemia,
and chronic granulomatous disease (Hu and Worton, 1992;
Borgato et al, 2001). Our patient represents the first case in
which a large duplication mutation has been associated to
JEB. The mechanism through which gross gene rearrange-
ments (duplications or deletions) occur is unequal recom-
bination, either between homologous chromosomes or
Figure 3
Patient 15: molecular characterization. (a)
Immunofluorescence staining of patient’s skin
using mAb GB3, directed against the het-
erotrimeric laminin-5. Laminin-5 immunolabeling
appears attenuated in patient’s skin compared
with normal skin. Scale bar: 20 mm. (b) Immuno-
precipitation of laminin-5 from media of 35S-
labeled keratinocytes from the patient (P) and a
normal control (C), using mAb K140 specific to
the b3 chain. The position of the three laminin-5
chains on SDS gel under reducing condition is
indicated. The laminin b3 polypeptide migrates
at 140 kDa in normal control (wt b3), whereas
only a shortened b3 chain of approximately 130
kDa (D b3) is immunoprecipitated from patient’s
keratinocyte medium. Numbers refer to the po-
sition of marker proteins in kilodaltons. (c) Iden-
tification of a homozygous 2 bp deletion
mutation (1587delAG) in exon 13 of the LAMB3
gene. Mutation 1587delAG leads to a frameshift
and results in a PTC formation within exon 14. (d)
Gel electrophoresis analysis of the cDNA prod-
ucts amplified with primer pair spanning exons
12–17. A single faster migrating band of 618 bp
is visible in the proband (P), whereas the ex-
pected 999 bp band is present in the control
sample, but not in the patient, indicating rapid
decay of the mutant full-length mRNA. Direct
sequencing of the 618 bp cDNA fragment iden-
tified in-frame b3 mutant transcripts carrying
both the 1587delAG mutation and the internal
deletion of exon 14 (379 bp). The exon 14-
skipped transcript is faintly detected as a band
of 620 bp in the control sample (C) as well as in
six other keratinocyte strains established from
skin biopsies of healthy volunteers and its iden-
tity was checked by nucleotide sequencing.
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between sister chromatids of the same chromosome. Two
main types of recombination events are currently recog-
nized: homologous unequal recombination between gene
sequences or repetitive sequence elements (Ringpfeil et al,
2001), and non-homologous (illegitimate) recombination be-
tween DNA sequences with little or no homology (van Rijk
and Bloemendal, 2003). Mutation Ex11_Ex18dup in LAMC2
is the result of non-homologous recombination, because
little homology (o50%) is present in the breakpoint regions.
Although most recombination events lead to tandem dupli-
cations, however, in our patient the location of the inserted
DNA segment and the nucleotide sequence of the break-
point regions indicate occurrence of two independent
illegitimate recombination events (Fig 1g). A first rearrange-
ment might have arisen from the juxtaposition of non-ho-
mologous sequences between introns 18 and 6, leading to
the tandem duplication of the gene segment spanning ex-
ons 7–18 and resulting in the insertion of two filler cytosine
at the recombination site (30 junction) (Borgato et al, 2001).
Then, deletion of the region encompassing exons 7–10 has
occurred, upstream the tandem duplication breakpoints,
through non-homologous recombination between chroma-
tids involving a 7 bp sequence motif (TCAGACC) shared by
introns 6 and 10 and located at the breakpoints (50 junction).
The final result of this complex gene rearrangement has
been the duplication of the gene segment encompassing
exons 11–18 (Fig 1h).
Among the Italian non-H JEB patients, four had muta-
tions in LAMB3, three in LAMA3, and one in LAMC2 (Table I).
In five of eight cases, a PTC mutation was found in com-
bination with a splice site or a missense mutation or an as
yet unidentified genetic defect. Two patients harbored
splice site mutations on both alleles (no. 18 and 19, this
study). All described splice site mutations have been shown
to allow the synthesis of variably reduced amounts of either
internally deleted or mutant full-length laminin-5 chain
mRNA molecules (Posteraro et al, 1998; Castiglia et al,
2001; this study). The missense mutation G1506E in LAMA3
did not affect mRNA stability but interfered with the proper
folding of the fourth carboxy-terminal globular domain (LG4)
resulting in the retention of most of the mutated a3 poly-
peptide within the endoplasmic reticulum (Scaturro et al,
2003). Consequently, in all non-H JEB cases detectable
amounts of mutant laminin-5 were secreted, underwent
physiologic extracellular maturation and correctly localized
within the cutaneous BMZ, as attested by radioimmuno-
precipitation of cultured keratinocyte media and/or
immunofluorescence analysis of skin biopsies. The remain-
ing non-H JEB patient carried a homozygous 2 bp deletion
(1587delAG) in exon 13 of LAMB3. Our findings are in
agreement with those described in a French non-H JEB
patient who was a compound heterozygote for the same
deletion mutation and the hot spot R635X (Gache et al,
2001). The 1587delAG mutation restores the open-reading
frame of a naturally occurring out-of-frame exon 14-skipped
mRNA transcript which, thus, escapes nonsense-mediated
decay (Hentze and Kulozik, 1999) and can accumulate in
the cells as a single mRNA species. In patient’s keratin-
ocytes, the rescue of the mutant in frame mRNA allows the
synthesis of shortened b3 polypeptides, internally deleted
of 127 amino acids within domains II and III, which are able
to assemble into laminin-5 heterotrimers and to be secreted
in the cutaneous BMZ of patient’s skin (Gache et al, 2001;
this study).
The survey of the Italian JEB patients included in this
study has shown the presence of five recurrent mutations in
laminin-5 genes. In particular, two common Italian muta-
tions, R95X in LAMC2 and the W143X in LAMB3, show a
regional distribution, as they were found in patients from
Sicily and Campania, respectively. Haplotype analysis and
regional distribution indicate a common ancestral origin for
these two mutations. Altogether, the five frequent mutations
were found in 44% of the laminin-5 JEB alleles and there-
fore Italian patients affected by JEB should be first screened
for these mutations. In case search for frequent mutations
fails, screening should be extended to all exons of the gene
encoding for the defective chain by heteroduplex analysis
on amplified genomic DNA or by RT-PCR and sequence
analysis of the corresponding cDNA fragments. This muta-
tion detection strategy allowed us to reveal mutations in
almost all the patients analyzed. Two of the mutations, both
affecting one allele of the LAMB3 gene in two distinct pa-
tients, however, could not be determined (5% of all alleles).
The inability to detect mutations in these cases can be due
to the presence of a large intragenic deletion/duplication or
to an intronic mutation further away from canonical splice
sites. Indeed, our mutation detection strategy based on
PCR amplification of relatively small exons or cDNA tracts
Table III. Laminin-5 recurrent mutations in Italian JEB patients
Mutation Number of mutated alleles % of mutated alleles Italian geographic origin Detection method
LAMB3
R635X 4 10.5 Widespread BglII
W143X 4 10.5 Campania BstNI
29insC 3 7.9 Widespread Sequencing
E210K 2 5.3 Widespread AlwNI
LAMC2
R95X 4 10.5 Sicily TaqI
JEB, junctional epidermolysis bullosa.
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does not allow us to rule out these possibilities. Long-range
RT-PCR and/or Southern blot analyses may be helpful in
identifying these types of genetic lesion, although they were
unsuccessful when applied in patients 1 and 12. Further-
more, mutations in regulatory sequences not included in the
routine screening of the LAMB3 gene and localized up-
stream from the first coding exon may also result in low
or absent expression of the involved allele (Pulkkinen et al,
1995a).
In conclusion, our study expands the repertoire of la-
minin-5 mutated alleles associated to JEB, discloses mu-
tations confined to the Italian genetic background and
contributes to a better understanding of the physiologic
functions of laminin-5 that may be useful in predicting mu-
tation consequences in JEB patients.
Materials and Methods
Patients and biologic materials Nineteen Caucasian patients, 11
affected with H JEB and eight with non-H JEB, were included in
this study. JEB was diagnosed on the basis of clinical features,
immunofluorescence antigen mapping, and ultrastructural exam-
ination of skin biopsies (Castiglia et al, 2001; Gardella et al, 2002;
Scaturro et al, 2003). In most patients, a skin biopsy was also
processed for keratinocyte cultures as described (Zambruno et al,
1995). Peripheral blood samples were obtained from all patients
and their parents, and genomic DNA was isolated by standard
procedures.
The study was conducted in accordance to the Declaration of
Helsinki guidelines and approved by the IDI-IRCCS Ethic Commit-
tee; all patients gave informed consent.
Immunodetection studies Immunofluorescence of skin biopsies
and radioimmunoprecipitation of cell lysates and culture medium
were performed according to previously described procedures
(Castiglia et al, 2001). The following monoclonal antibodies (mAb)
and polyclonal antisera (pAb) were used (Castiglia et al, 2001; ref-
erences therein): GB3 (mouse mAb to laminin-5), K140 (mouse
mAb to the lam inin b3 chain; gift from R. Burgeson, Cutaneous
Biology Research Center, Charlestown, Massachusetts), BM165
(mAb to the laminin a3 chain, gift from R. Burgeson), a pAb raised
against the NH2-terminal region of the processed (105 kDa) human
laminin g2 chain (Scaturro et al, 2003), 1A8C (mouse mAb to col-
lagen XVII; gift from K. Owaribe, Nagoya University, Japan), G0H3
(rat mAb to the a6 integrin subunit; gift from A. Sonnenberg, The
Netherland Cancer Institute, Amsterdam, The Netherlands), 3E1
(mouse mAb to the b4 integrin subunit; Telios Pharmaceuticals,
San Diego, California), CIV 22 (mouse mAb to human type IV col-
lagen; DAKO, Glostrup, Denmark), and LH7.2 (mouse mAb to type
VII collagen; Sigma Immunochemical, St Louise, Missouri).
Mutation detection and veriﬁcation The LAMA3, LAMB3, or
LAMC2 genes were scanned by PCR amplification of individual
exons and flanking intronic sequences using specific primers and
100 ng of genomic DNA as a template (Pulkkinen et al, 1995b,
1997a, 1998; Nakano et al, 2002a). PCR reactions were performed
in a final volume of 50 mL containing 1 mM MgCl2, 25 pmol of each
primer, 200 mM dNTP, and 2 U of AmpliTaq Gold DNA polymerase
(Applied Biosystems, Foster City, California); cycling conditions
were 10 min at 941C, followed by 35 cycles of 30 s at 941C, 30 s at
551C–601C, and 30 s at 721C and then 10 min at 721C. PCR prod-
ucts were subjected to heteroduplex analysis (MDE), following the
manufacturer’s protocol (FMC Corporation, Rockland, Maine), and
those presenting with heteroduplexes were directly sequenced
(ABI Prism 377, Applied Biosystems).
Alternatively, search for mutations in LAMB3 and LAMC2 genes
was performed at the mRNA level. Total RNA was purified from
cultured patient and normal keratinocytes by the guanidinium-
thiocyanate method. In all, 2.5 mg of total RNA were reverse tran-
scribed (Posteraro et al, 1998) and PCR fragments corresponding
to the full-length LAMB3 or LAMC2 cDNA sequences were gen-
erated using primers and conditions already described (Pulkkinen
et al, 1995b, 1997a); the amplified products were subjected to
direct automated sequencing.
Mutation verification was carried out by endonuclease restric-
tion digestion or allele specific oligonucleotide hybridization.
To allow easy comparison with previously reported genetic de-
fects affecting LAMA3 in JEB patients, the mutation position was
determined according to the originally deposited LAMA3 cDNA
sequence (GenBank accession no. L34155), encoding the a3a
isoform and not following the revised version of the LAMA3A tran-
script (GenBank accession no. AY327114) that includes 33 addi-
tional base pairs at the 50 end (McLean et al, 2003).
RNA studies For northern blot analysis, 20 mg of total RNA were
transferred on nylon membranes and hybridized with 32P-labeled
LAMA3, LAMB3, and LAMC2 specific probes, or the GAPDH probe
for loading control (Castiglia et al, 2001). In order to evaluate the
effects on pre-mRNA splicing of putative splice site mutations,
cDNA synthesized as described was amplified with the following
primer pairs: 50-GGGATGCCTCCAGCAGTGAG-30 and 50-GCCA-
TTGCTGTTACAACTGC-30 (nt 35 to 519) and 50-AGAGGCTTGCT-
GTTCTTTG-30 and 50-ACTGGGTTGAAAGGTCTGAA-30 (nt 3034–
3549) spanning LAMA3 cDNA (GenBank accession no. L34155)
in patient no. 19; 50-AACGTAGGTGGTCCCAAATG-30 and 50-AC-
AGAGCTTGTTGAAGGTGG-30 (nt 1366–2364) spanning LAMB3
cDNA (Pulkkinen et al, 1995b) in patient no. 15. The resulting ab-
errant cDNA fragments were excised from agarose gels, purified,
and subjected to direct automated sequencing.
Southern blot analysis To search for genetic defects in patient
no. 9, 10 mg of genomic DNA obtained from the blood of the patient
and a normal control were fully digested with EcoRI restriction
enzyme (Roche Molecular Diagnostics, Mannheim, Germany), sep-
arated on 1% agarose gel, and transferred to nylon membranes
(Hybond Nþ ), following the manufacturer’s protocol (Amersham
Biosciences, Little Chalfont, UK). The membranes were hybridized
with 32P-labeled DNA probes corresponding to exon 6 or 18 of the
LAMC2 gene. Probes were generated by genomic PCR with the
primer pairs previously described (Pulkkinen et al, 1997a).
Cloning of the junction fragments To verify the occurrence of
aberrant genomic junctions in LAMC2 in patient no. 9, long-range
PCR were carried out in a total volume of 50 mL containing 100 ng
of DNA. Reactions were performed using the Expand High Fidelity
Taq Polymerase (Roche Molecular Diagnostics), according to the
manufacturer’s protocol and cycling conditions. The sequence of
the primers used were In17F (50-TATTCATATGGTGGGCATTC-30)
and In7R (50-TCATAGCCCAAAGTGTCATA-30) that hybridize within
introns 17 and 7, respectively (Tann, 551C); In5F (50-ATAGATGATG
AGGGCTTGTC-30) and In11R (50-AAGTGCATACGTACACAGGC-30)
that hybridize within introns 5 and 11, respectively (Tann, 571C).
PCR products corresponding to the junction fragments were ex-
cised from agarose gels, purified, and directly sequenced.
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